Id |
Subject |
Object |
Predicate |
Lexical cue |
T28 |
0-24 |
Sentence |
denotes |
Participants and methods |
T29 |
25-124 |
Sentence |
denotes |
The expert panel is comprised of 29 participants from seven European countries, the USA and Taiwan. |
T30 |
125-485 |
Sentence |
denotes |
To ensure heterogenicity, participants were selected from various fields of expertise: medical microbiology (PEV, KL, CL-F, TRR), infectious diseases (BJAR, MB, TC, CJC, OAC, DRG, NAFJ, BJK, OL, MH-N, TFP, FLvdV), intensive care medicine (EA, SB, PD, PW-LL, IM-L, JAS, LV, JW), clinical pharmacology (RJMB, RL, IS), public health (TC) and hematology (OAC, JM). |
T31 |
486-653 |
Sentence |
denotes |
Selected participants furthermore had specific expertise in epidemiology, diagnosis and management of invasive fungal diseases or fungal disease guideline development. |
T32 |
654-706 |
Sentence |
denotes |
The meeting was prepared by PEV, RJMB, JW and FLvdV. |
T33 |
707-779 |
Sentence |
denotes |
Case definitions were developed through a process of informal consensus. |
T34 |
780-1115 |
Sentence |
denotes |
Although a systematic literature review was not performed, experts in the field presented overviews regarding epidemiology, pathogenesis, diagnosis and treatment of IAPA, which were followed by a group discussion process designed to allow members of the group to voice their opinions and contribute equally to the decision-making [12]. |
T35 |
1116-1194 |
Sentence |
denotes |
The goal of the consensus process was to bring the group to general agreement. |
T36 |
1195-1380 |
Sentence |
denotes |
Presentations and initial discussions took place on a single day meeting in April 2019 in Amsterdam and were continued through electronic exchange of views until consensus was achieved. |
T37 |
1381-1568 |
Sentence |
denotes |
The chosen framework included host and risk factors, clinical factors and mycological evidence, similar to the framework in the EORTC/MSGERC definitions and the AspICU algorithm [10, 11]. |
T38 |
1569-1662 |
Sentence |
denotes |
A medical writer made notes of the meeting, which were used as input to write the manuscript. |
T39 |
1663-1779 |
Sentence |
denotes |
A first draft manuscript was prepared by PEV, BJAR, RJMB, JW and FLvdV and circulated for comments from all experts. |
T40 |
1780-1833 |
Sentence |
denotes |
The experts reviewed and commented on the manuscript. |
T41 |
1834-1900 |
Sentence |
denotes |
Using these comments, a final version was circulated for approval. |
T42 |
1901-2115 |
Sentence |
denotes |
The logistics of the meeting were handled by a certified Congress organizer (Congress Care, s’Hertogenbosch, the Netherlands) with financial support of Pfizer (Pfizer B.V., Capelle aan den IJssel, the Netherlands). |
T43 |
2116-2286 |
Sentence |
denotes |
Congress Care and Pfizer had no influence on the selection of participants, selected topics, discussions, preparation and final approval of the content of the manuscript. |